TEVA PHARMACEUTICAL INDUSTRIES LTD - COMMON STOCK Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
1,173,398,160
Price per share
$20.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
31,565
Total reported value
$637,613
% of total 13F portfolios
0%
Share change
-12,729
Value change
-$257,126
Number of holders
1
Price from insider filings
$20.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TEVA PHARMACEUTICAL INDUSTRIES LTD - COMMON STOCK based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Harel Insurance Investments & Financial Services Ltd. 5.1% 58,118,222 Harel Insurance Investments & Financial Services Ltd 29 Sep 2025
FMR LLC 2.1% -60% -$561,363,714 24,641,361 -58% FMR LLC 30 Sep 2025

As of 30 Sep 2025, 1 institutional investors reported holding 31,565 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD - COMMON STOCK. This represents 0% of the company’s total 1,173,398,160 outstanding shares.

Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - COMMON STOCK across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 31,565 $637,613 -$257,126 $20.20 1
2025 Q2 44,294 $742,367 +$742,367 $16.76 1